In multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE) autoaggressive CD4 + T cells cross the blood-brain barrier (BBB) and cause neuroinflammation. Therapeutic targeting of CD4 + T-cell trafficking into the CNS by blocking α4-integrins has proven beneficial for the treatment of MS but comes with associated risks, probably due to blocking CD8 + T cell mediated CNS immune surveillance. Trapping of CNS inflammatory cells was not due to increased inflammatory cell proliferation. Neither a loss of BBB integrity or BBB polarity potentially affecting local chemokine gradients nor a lack of focal gelatinase activation required for CNS parenchymal immune cell entry across the glia limitans could be detected in JAM-B −/− mice. Lack of a role for JAM-B in the effector phase of EAE was supported by the observation that we did not detect any role for JAM-B in EAE pathogenesis, when EAE was elicited by in vitro activated MOG aa35-55-specific CD4 + effector T cells. On the other hand, we also failed to demonstrate any role of JAM-B in in vivo priming, proliferation or polarization of MOG aa35-55 -specific CD4 + T cells in peripheral immune organs. Finally, our study excludes expression of and thus a role for JAM-B on peripheral and CNS infiltrating myeloid cells. Taken together, although endothelial JAM-B is not required for immune cell trafficking across the BBB in EAE, in its absence accumulation of inflammatory cells mainly in CNS leptomeningeal spaces leads to amelioration of EAE.
In multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE) autoaggressive CD4 + T cells cross the blood-brain barrier (BBB) and cause neuroinflammation. Therapeutic targeting of CD4 + T-cell trafficking into the CNS by blocking α4-integrins has proven beneficial for the treatment of MS but comes with associated risks, probably due to blocking CD8 + T cell mediated CNS immune surveillance.
Our recent observations show that CD8 + T cells also rely on α4β1-integrins to cross the BBB. Trapping of CNS inflammatory cells was not due to increased inflammatory cell proliferation. Neither a loss of BBB integrity or BBB polarity potentially affecting local chemokine gradients nor a lack of focal gelatinase activation required for CNS parenchymal immune cell entry across the glia limitans could be detected in JAM-B −/− mice. Lack of a role for JAM-B in the effector phase of EAE was supported by the observation that we did not detect any role for JAM-B in EAE pathogenesis, when EAE was elicited by in vitro activated MOG aa35-55-specific CD4 + effector T cells. On the other hand, we also failed to demonstrate any role of JAM-B in in vivo priming, proliferation or polarization of MOG aa35-55 -specific CD4 + T cells in peripheral immune organs. Finally, our study excludes expression of and thus a role for JAM-B on peripheral and CNS infiltrating myeloid cells. Taken together, although endothelial JAM-B is not required for immune cell trafficking across the BBB in EAE, in its absence accumulation of inflammatory cells mainly in CNS leptomeningeal spaces leads to amelioration of EAE.
Introduction
The central nervous system (CNS) coordinates all body and mental functions in vertebrates and proper communication of its neurons requires CNS homeostasis. Protection from the changing milieu of the blood stream is provided by the endothelial blood-brain barrier (BBB). The BBB is established by biochemically and ultrastructurally unique microvascular endothelium that prohibits free diffusion of molecules into the CNS by its low pinocytotic activity and the complex and continuous tight junctions sealing the inter-endothelial space. At the same time, the BBB ensures transport of nutrients into and toxic metabolites out of the CNS by expression of carriers and transporters and efflux pumps (Abbott et al., 2010; Campos-Bedolla et al., 2014; Engelhardt and Coisne, 2011) . In its barrier function, the BBB also controls the migration of immune cells across the BBB, which occurs at the level of post-capillary venules. The CNS is an immune privileged organ, in
